| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 4.78B | 4.70B | 4.64B | 4.47B | 3.96B |
| Gross Profit | 565.00M | 1.85B | 1.66B | 1.63B | 491.00M |
| EBITDA | 591.00M | 392.00M | 330.00M | 273.00M | 281.00M |
| Net Income | 70.00M | -31.00M | -76.00M | -14.00M | -47.00M |
Balance Sheet | |||||
| Total Assets | 4.67B | 5.00B | 4.77B | 5.05B | 4.57B |
| Cash, Cash Equivalents and Short-Term Investments | 48.00M | 28.00M | 54.00M | 111.00M | 175.00M |
| Total Debt | 1.94B | 2.12B | 1.94B | 2.07B | 1.52B |
| Total Liabilities | 2.92B | 3.23B | 2.99B | 3.13B | 2.64B |
| Stockholders Equity | 1.72B | 1.72B | 1.74B | 1.87B | 1.88B |
Cash Flow | |||||
| Free Cash Flow | 227.00M | 88.00M | 159.00M | -362.00M | -90.00M |
| Operating Cash Flow | 379.00M | 272.00M | 510.00M | 144.00M | 211.00M |
| Investing Cash Flow | -94.00M | -150.00M | -332.00M | -486.00M | -247.00M |
| Financing Cash Flow | -263.00M | -149.00M | -225.00M | 272.00M | -529.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | C$2.78B | 14.22 | 10.45% | 7.11% | 3.19% | -0.26% | |
73 Outperform | C$15.97B | 18.88 | 14.88% | 1.46% | 7.12% | 17.15% | |
70 Neutral | C$1.93B | 9.65 | 8.95% | 8.22% | -2.45% | 44.20% | |
65 Neutral | C$89.99M | 7.49 | 15.15% | 19.66% | -4.69% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | C$335.96M | 18.41 | ― | ― | ― | ― | |
53 Neutral | $1.23B | 18.01 | 1.16% | 3.90% | 3.50% | ― |
Cascades reported fourth-quarter 2025 sales of $1.197 billion, with operating income rising to $76 million and earnings per share improving to $0.37, reflecting stronger packaging performance offset by weaker tissue results and a costly power outage. For full-year 2025, sales grew to $4.776 billion, operating income more than doubled to $235 million, adjusted EBITDA climbed to $576 million, and net debt fell to $1.896 billion, as asset sales surpassed the company’s monetization target and strategic actions began to deliver operational and financial gains.
Management expects first-quarter results to soften sequentially due to normal seasonality, weather-driven cost pressures and lingering impacts from the power outage, though performance should remain above prior-year levels. Looking to 2026, Cascades anticipates results will exceed 2025 as it continues deleveraging, benefits from profitability initiatives and consolidates its positioning in packaging and tissue despite macroeconomic uncertainty.
The most recent analyst rating on (TSE:CAS) stock is a Hold with a C$15.00 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.
Cascades Inc. is exiting its honeycomb paperboard and partition packaging segments, closing three plants in Berthierville and Saint-Césaire, Quebec, and York, Pennsylvania, as it concentrates on strategic markets where it sees better long-term growth and profitability. The move underscores a shift away from declining niche markets toward strengthening its core packaging platform, while the adjacent Cascades Sonoco – Berthierville plant remains unaffected.
The Berthierville honeycomb packaging facility shuts immediately, affecting 52 employees, with certain assets sold to Emballages LM for about $9 million to help ensure service continuity for customers. The York plant, with 37 employees, will close by February 19, 2026, and the Saint-Césaire cardboard partition facility, which employs 25 people and has suffered from falling demand and geographic disadvantages, will cease operations by April 17, 2026.
Cascades will provide transition support and job search assistance to affected workers and is encouraging them to seek roles at other company sites. Management frames the closures as a necessary optimization to realign assets with priority sectors and reinforce Cascades’ position as a preferred partner in its chosen packaging markets, signaling a tighter operational focus and potential efficiency gains for stakeholders.
The most recent analyst rating on (TSE:CAS) stock is a Hold with a C$15.00 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.
Cascades Inc. has agreed to sell its corrugated packaging plant in Richmond, British Columbia, to Crown Paper Group for $65.5 million, including real estate assets and subject to customary adjustments and closing conditions. The divestiture is part of Cascades’ broader strategy to optimize its operational footprint and reduce debt by reallocating capital to core markets, with management emphasizing that the asset sale monetizes valuable real estate while having no material impact on the packaging segment’s cash flow profile. Because the Richmond facility had limited integration and synergy potential within Cascades’ network due to its geography, the plant is seen as a stronger strategic fit for Crown, whose existing integrated containerboard mill and regional presence in the Pacific Northwest and Western Canada are expected to ensure a seamless transition for employees and customers, reinforce Crown’s regional expansion, and maintain ongoing investment in the site.
The most recent analyst rating on (TSE:CAS) stock is a Buy with a C$16.00 price target. To see the full list of analyst forecasts on Cascades stock, see the TSE:CAS Stock Forecast page.